Reduced hippocampal glutamate-glutamine levels in irritable bowel syndrome: Preliminary findings using magnetic resonance spectroscopy

American Journal of Gastroenterology

Volumn 106, Issue 8, 2011, Pages 1503-1511

  Niddam, David M ^a,b   Tsai, Shang Yueh ^c   Lu, Ching Liang ^a,b   Ko, Cheng Wen ^d   Hsieh, Jen Chuen ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADENOHYPOPHYSIS HYPOFUNCTION; ADULT; AROUSAL; ARTICLE; BRAIN REGION; BRAIN SIZE; CELL PROLIFERATION; CHRONIC PAIN; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; EMOTIONAL STRESS; FEMALE; GLIA CELL; HEMISPHERE; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IRRITABLE COLON; MALE; NEUROIMAGING; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAIN ASSESSMENT; PRIORITY JOURNAL; STRESS;

EID: 85027944400     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.120     Document Type: Article

References (67)

1. Grundmann O, Yoon SL. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners. J Gastroenterol Hepatol 2010; 25: 691-9.
2. Saito YA, Schoenfeld P, Locke GR 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 97: 1910-5.
3. Mayer EA, Naliboff BD, Chang L. Evolving pathophysiological model of functional gastrointestinal disorders: implications for treatment. Eur J Surg Suppl 2002; 587: 3-9. (Pubitemid 36359574)
4. Lembo T, Munakata J, Mertz H et al. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology 1994; 107: 1686-96. (Pubitemid 24357622)
5. Price DD, Zhou Q, Moshiree B et al. Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. J Pain 2006; 7: 529-35. (Pubitemid 44119285)
6. Coffin B, Bouhassira D, Sabate JM et al. Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome. Gut 2004; 53: 1465-70. (Pubitemid 39265267)
7. Hall GB, Kamath MV, Collins S et al. Heightened central affective response to visceral sensations of pain and discomfort in IBS. Neurogastroenterol Motil 2009; 22: 11.
8. Mertz H, Morgan V, Tanner G et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000; 118: 842-8. (Pubitemid 30243747)
9. Naliboff BD, Derbyshire SW, Munakata J et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 2001; 63: 365-75. (Pubitemid 32467111)
10. Verne GN, Himes NC, Robinson ME et al. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain 2003; 103: 99-110. (Pubitemid 36579090)
11. Blanchard EB, Lackner JM, Jaccard J et al. The role of stress in symptom exacerbation among IBS patients. J Psychosom Res 2008; 64: 119-28.
12. Whitehead WE, Crowell MD, Robinson JC et al. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33 : 825-30.
13. Lackner JM, Quigley BM, Blanchard EB. Depression and abdominal pain in IBS patients: the mediating role of catastrophizing. Psychosom Med 2004; 66: 435-41. (Pubitemid 38668417)
14. Bohmelt AH, Nater UM, Franke S et al. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med 2005; 67: 288-94. (Pubitemid 40410966)
15. Chang L, Sundaresh S, Elliott J et al. Dysregulation of the hypothalamicpituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 2009; 21: 149-59.
16. FitzGerald LZ, Kehoe P, Sinha K. Hypothalamic-pituitary-adrenal axis dysregulation in women with irritable bowel syndrome in response to acute physical stress. West J Nurs Res 2009; 31: 818-36.
17. Bannerman DM, Rawlins JN, McHugh SB et al. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 2004; 28: 273-83. (Pubitemid 38844376)
18. Gol A, Faibisch GM. Hippocampectomy for relief of intractable pain. Tex Med 1966; 62: 76-9.
19. Halgren E, Walter RD, Cherlow DG et al. Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain 1978; 101: 83-117. (Pubitemid 8371554)
20. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87: 873-904. (Pubitemid 47086281)
21. McKenna JE, Melzack R. Blocking NMDA receptors in the hippocampal dentate gyrus with AP5 produces analgesia in the formalin pain test. Exp Neurol 2001; 172: 92-9. (Pubitemid 33141157)
22. Prado WA, Roberts MH. An assessment of the antinociceptive and aversive effects of stimulating identified sites in the rat brain. Brain Res 1985; 340: 219-28. (Pubitemid 15226699)
23. Soares DP, Law M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 2009; 64: 12-21.
24. Huang W, Alexander GE, Daly EM et al. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. Am J Psychiatry 1999; 156: 1879-86.
25. Emad Y, Ragab Y, Zeinhom F et al. Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. J Rheumatol 2008; 35: 1371-7. (Pubitemid 352000787)
26. Harris RE, Sundgren PC, Craig AD et al. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 2009; 60: 3146-52.
27. Wood PB, Ledbetter CR, Glabus MF et al. Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features. J Pain 2009; 10: 47-52.
28. Grachev ID, Fredrickson BE, Apkarian AV. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain 2000; 89: 7-18.
29. Grachev ID, Fredrickson BE, Apkarian AV. Brain chemistry reflects dual states of pain and anxiety in chronic low back pain. J Neural Transm 2002; 109: 1309-34.
30. Fukui S, Matsuno M, Inubushi T et al. N-Acetylaspartate concentrations in the thalami of neuropathic pain patients and healthy comparison subjects measured with (1)H-MRS. Magn Reson Imaging 2006; 24: 75-9. (Pubitemid 43061206)
31. Pattany PM, Yezierski RP, Widerstrom-Noga EG et al. Proton magnetic resonance spectroscopy of the thalamus in patients with chronic neuropathic pain aft er spinal cord injury. Am J Neuroradiol 2002; 23: 901-5. (Pubitemid 34663428)
32. Sorensen L, Siddall PJ, Trenell MI et al. Diff erences in metabolites in painprocessing brain regions in patients with diabetes and painful neuropathy. Diabetes Care 2008; 31: 980-1.
33. Gu T, Ma XX, Xu YH et al. Metabolite concentration ratios in thalami of patients with migraine and trigeminal neuralgia measured with 1H-MRS. Neurol Res 2008; 30: 229-33. (Pubitemid 351769413)
34. Sarmento E, Moreira P, Brito C et al. Proton spectroscopy in patients with post-traumatic headache attributed to mild head injury. Headache 2009; 49: 1345-52.
35. Wang SJ, Lirng JF, Fuh JL et al. Reduction in hypothalamic 1H-MRS metabolite ratios in patients with cluster headache. J Neurol Neurosurg Psychiatry 2006; 77: 622-5.
36. Dichgans M, Herzog J, Freilinger T et al. 1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1. Neurology 2005; 64: 608-13. (Pubitemid 40261887)
37. Prescot A, Becerra L, Pendse G et al. Excitatory neurotransmitters in brain regions in interictal migraine patients. Mol Pain 2009; 5: 34.
38. Sarchielli P, Tarducci R, Presciutti O et al. Functional 1H-MRS findings in migraine patients with and without aura assessed interictally. Neuroimage 2005; 24: 1025-31. (Pubitemid 40164504)
39. Longstreth GF, Th ompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
40. Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep 1974; 34: 1184-6.
41. Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess 1995; 7: 524-32. (Pubitemid 26017352)
42. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-9. (Pubitemid 23360802)
43. Barker PB, Soher BJ, Blackband SJ et al. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed 1993; 6: 89-94.
44. Christiansen P, Henriksen O, Stubgaard M et al. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging 1993; 11: 107-18.
45. Geurts JJ, Barkhof F, Castelijns JA et al. Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility. J Magn Reson Imaging 2004; 20: 366-71. (Pubitemid 39121932)
46. Sandi C. Stress, cognitive impairment and cell adhesion molecules. Nat Rev Neurosci 2004; 5: 917-30. (Pubitemid 39593355)
47. Hertz L, Zielke HR. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci 2004; 27: 735-43. (Pubitemid 39488077)
48. McKinney RA. Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling. J Physiol 2009; 588: 107-16.
49. Dinan TG, Quigley EM, Ahmed SM et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006; 130: 304-11. (Pubitemid 43202030)
50. Ehlert U, Nater UM, Bohmelt A. High and low unstimulated salivary cortisol levels correspond to diff erent symptoms of functional gastrointestinal disorders. J Psychosom Res 2005; 59: 7-10. (Pubitemid 41207871)
51. Heim C, Nemeroff CB. Neurobiology of posttraumatic stress disorder. CNS Spectr 2009; 14: 13-24.
52. Heim C, Shugart M, Craighead WE et al. Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol 2010; 52: 671-90.
53. Yehuda R. Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Ann N Y Acad Sci 2006; 1071: 137-66. (Pubitemid 44126726)
54. Cole MA, Kim PJ, Kalman BA et al. Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies. Psychoneuroendocrinology 2000; 25: 151-67. (Pubitemid 29525388)
55. McGowan PO, Sasaki A, Alessio AC et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009; 12: 342-8.
56. Apfel BA, Ross J, Hlavin J et al. Hippocampal volume diff erences in gulf war veterans with current versus lifetime posttraumatic stress disorder symptoms. Biol Psychiatry 2010; 2010: 20.
57. Bremner JD, Randall P, Scott TM et al. MRI-based measurement of hippo campal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995; 152: 973-81.
58. Wang Z, Neylan TC, Mueller SG et al. Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder. Arch Gen Psychiatry 2010; 67: 296-303.
59. Neylan TC, Schuff N, Lenoci M et al. Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol Psychiatry 2003; 54: 1118-21. (Pubitemid 37415047)
60. Drossman DA, Leserman J, Hu JB. Gastrointestinal diagnosis, abuse history, and effects on health status. Gastroenterology 1996; 111: 1159-61. (Pubitemid 26327627)
61. Blankstein U, Chen J, Diamant NE et al. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology 2010; 138: 1783-9.
62. Barkus C, McHugh SB, Sprengel R et al. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur J Pharmacol 2009; 626: 49-56.
63. Rey E, Moreno Ortega M, Garcia Alonso MO et al. Constructive thinking, rational intelligence and irritable bowel syndrome. World J Gastroenterol 2009; 15: 3106-13.
64. Geurts JJ, Reuling IE, Vrenken H et al. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med 2006; 55: 478-83. (Pubitemid 43352544)
65. Milne A, MacQueen GM, Yucel K et al. Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study. Neuroimage 2009; 47: 36-41.
66. Schirmer T, Auer DP. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 2000; 13: 28-36. (Pubitemid 30136999)
67. Brooks WM, Friedman SD, Stidley CA. Reproducibility of 1H-MRS in vivo. Magn Reson Med 1999; 41: 193-7.